{"id":14803,"date":"2021-09-21T13:48:37","date_gmt":"2021-09-21T13:48:37","guid":{"rendered":"https:\/\/interhospi.com\/?p=14803"},"modified":"2021-09-21T13:48:37","modified_gmt":"2021-09-21T13:48:37","slug":"ihs-announces-ce-mark-for-insignis-syringe-infusion-system","status":"publish","type":"post","link":"https:\/\/interhospi.com\/ihs-announces-ce-mark-for-insignis-syringe-infusion-system\/","title":{"rendered":"IHS announces CE Mark for Insignis Syringe Infusion System"},"content":{"rendered":"
\n

<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

IHS announces CE Mark for Insignis Syringe Infusion System<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Innovative Health Sciences has received ISO 13485 quality management system and CE Mark certification for the Insignis Syringe Infusion System.<\/strong><\/p>\n

<\/p>\n

The Insignis Syringe Infusion System is the first combination of intravenous and subcutaneous non-electric infusion pump created for use with a selectable rate flow controller, the IV Controller and the OneSett.<\/p>\n

The Insignis System for intravenous administration answers the need for a portable, non-electric, versatile, cost-effective, and intuitive infusion pump to accurately deliver medications from KVO up to 250 ml\/hr with a direct reading selectable rate flow controller.<\/p>\n

For subcutaneous applications, the OneSett consists of a selectable rate flow controller attached directly to a subcutaneous needle set (1-4 leg configuration offering), which enables the user to select the flow rate (from 10 ml \u2013 60 ml) with the turn of a dial. The flow rate indicated on the dial is delivered to each needle site \u2013 no calculation required.<\/p>\n

The IHS infusion system addresses nearly every infusion therapy need and can support intermittent, \u2018pause\u2019 dosing, and is ideal for lengthy low-volume hospital infusions.<\/p>\n

\u201cThe IHS system represents a paradigm shift in simplicity, excellence, cost effectiveness, usability and patient-centred design,\u201d said Andrew Sealfon, IHS founder, Chairman, and CTO.<\/p>\n<\/div><\/section>
\n

\n
<\/span><\/span><\/div>
\n
<\/a><\/div><\/div><\/div>
\n